Fusion Inhibitors Market is anticipated to Expand At a Compound Annual Growth Rate (CAGR) from 2024 to 2033 | Bristol-Myers Squibb Company, Incyte, AstraZeneca
Fusion inhibitors are a type of antiviral drug used to treat HIV infections. They are a class of antiretroviral drugs that work by blocking the …
